DK0891776T3 - Granulær sammensætning omfattende simethicon og granulær vandfri calciumphosphat - Google Patents

Granulær sammensætning omfattende simethicon og granulær vandfri calciumphosphat

Info

Publication number
DK0891776T3
DK0891776T3 DK98305696T DK98305696T DK0891776T3 DK 0891776 T3 DK0891776 T3 DK 0891776T3 DK 98305696 T DK98305696 T DK 98305696T DK 98305696 T DK98305696 T DK 98305696T DK 0891776 T3 DK0891776 T3 DK 0891776T3
Authority
DK
Denmark
Prior art keywords
granular
simethicone
calcium phosphate
anhydrous calcium
composition
Prior art date
Application number
DK98305696T
Other languages
Danish (da)
English (en)
Inventor
Joseph R Luber
Glenn Madison
Gerard Mcnally
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Application granted granted Critical
Publication of DK0891776T3 publication Critical patent/DK0891776T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98305696T 1997-07-17 1998-07-16 Granulær sammensætning omfattende simethicon og granulær vandfri calciumphosphat DK0891776T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/896,189 US6103260A (en) 1997-07-17 1997-07-17 Simethicone/anhydrous calcium phosphate compositions

Publications (1)

Publication Number Publication Date
DK0891776T3 true DK0891776T3 (da) 2004-05-10

Family

ID=25405781

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98305696T DK0891776T3 (da) 1997-07-17 1998-07-16 Granulær sammensætning omfattende simethicon og granulær vandfri calciumphosphat

Country Status (19)

Country Link
US (1) US6103260A (cs)
EP (1) EP0891776B1 (cs)
JP (1) JPH1192387A (cs)
KR (1) KR100549355B1 (cs)
CN (1) CN1267106C (cs)
AR (1) AR013227A1 (cs)
AT (1) ATE259236T1 (cs)
AU (1) AU727271B2 (cs)
BR (1) BR9802487B1 (cs)
CZ (1) CZ294084B6 (cs)
DE (1) DE69821553T2 (cs)
DK (1) DK0891776T3 (cs)
ES (1) ES2216244T3 (cs)
HU (1) HUP9801615A3 (cs)
NZ (1) NZ330915A (cs)
PL (1) PL189988B1 (cs)
PT (1) PT891776E (cs)
RU (1) RU2216317C2 (cs)
ZA (1) ZA986338B (cs)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326384B1 (en) * 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6793934B1 (en) * 1999-12-08 2004-09-21 Shire Laboratories, Inc. Solid oral dosage form
KR100442174B1 (ko) * 2001-09-25 2004-07-30 (주)다산메디켐 이산화규소, 폴리소르베이트류 및디메칠폴리실록산(디메치콘, 시메치콘)을 함유하는소화기장애에 사용되는 고형의 신규의약조성물
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US20030229158A1 (en) * 2001-09-28 2003-12-11 Chen Jen Chi Polymer composition and dosage forms comprising the same
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
US20040253312A1 (en) 2001-09-28 2004-12-16 Sowden Harry S. Immediate release dosage form comprising shell having openings therein
US6837696B2 (en) * 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
US20040146559A1 (en) * 2002-09-28 2004-07-29 Sowden Harry S. Dosage forms having an inner core and outer shell with different shapes
AU2002330164A1 (en) 2001-09-28 2003-04-07 Mcneil-Ppc, Inc. Modified release dosage forms
US6753009B2 (en) 2002-03-13 2004-06-22 Mcneil-Ppc, Inc. Soft tablet containing high molecular weight polyethylene oxide
US7169450B2 (en) * 2002-05-15 2007-01-30 Mcneil-Ppc, Inc. Enrobed core
US20030232092A1 (en) * 2002-06-14 2003-12-18 Hasenmayer Donald L. Liquid antacid compositions
CA2499977A1 (en) 2002-09-28 2004-04-08 Mcneil-Ppc, Inc. Edible solid composition and dosage form
US7807197B2 (en) * 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US7341742B2 (en) * 2002-09-30 2008-03-11 L. Perrigo Company Simethicone containing tablet composition and method
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
TWI327913B (en) * 2003-03-12 2010-08-01 Novartis Ag Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid
US20040185093A1 (en) * 2003-03-18 2004-09-23 Szymczak Christopher E. Compositions containing sucralose
US20040186180A1 (en) * 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
US20040265373A1 (en) * 2003-06-27 2004-12-30 David Wynn Soft tablet containing high molecular weight cellulosics
US20040265372A1 (en) * 2003-06-27 2004-12-30 David Wynn Soft tablet containing high molecular weight cellulosics
US20050069590A1 (en) * 2003-09-30 2005-03-31 Buehler Gail K. Stable suspensions for medicinal dosages
US20050074514A1 (en) * 2003-10-02 2005-04-07 Anderson Oliver B. Zero cycle molding systems, methods and apparatuses for manufacturing dosage forms
US20050095299A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US20050095300A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US7879354B2 (en) * 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US8067029B2 (en) * 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US20050196442A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050196448A1 (en) * 2004-03-05 2005-09-08 Hai Yong Huang Polymeric compositions and dosage forms comprising the same
US20050196446A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050196447A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
CA2559239C (en) * 2004-04-13 2021-04-06 Boehringer Ingelheim International Gmbh Use of simethicone and sodium picosulphate in constipated patients suffering from bloated feeling and gas discomfort during the night
WO2006026337A1 (en) * 2004-08-25 2006-03-09 Fairfield Clinical Trials, Llc Combination of a proton pump inhibitor and a h2 antagonist for the treatment of gastroesophageal reflux disease
US20060062811A1 (en) * 2004-09-21 2006-03-23 Szymczak Christopher E Medicinal cooling emulsions
US20060088587A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060088586A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US8383159B2 (en) * 2004-10-27 2013-02-26 Mcneil-Ppc, Inc. Dosage forms having a microreliefed surface and methods and apparatus for their production
US20070190133A1 (en) * 2004-10-27 2007-08-16 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060087051A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20070281022A1 (en) * 2004-10-27 2007-12-06 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060088593A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US20070077300A1 (en) * 2005-09-30 2007-04-05 Wynn David W Oral compositions containing a salivation inducing agent
CO5790164A1 (es) * 2006-08-10 2007-08-31 Procaps S A Composicion farmaceutica solida que incluye en combinacion un agente regulador de la motilidad intestinal y un agente antiflatulento
ES2651444T3 (es) 2006-10-20 2018-01-26 Johnson & Johnson Consumer Inc. Combinación de acetaminofeno con ibuprofeno para el tratamiento del dolor
EP2094248A2 (en) * 2006-10-25 2009-09-02 McNeil-PPC, Inc. Ibuprofen composition
AU2007323674B2 (en) 2006-11-21 2013-05-23 Mcneil-Ppc, Inc. Modified release analgesic suspensions
US8491937B2 (en) * 2007-02-15 2013-07-23 Wyeth Llc Stability in vitamin and mineral supplements
US9833510B2 (en) * 2007-06-12 2017-12-05 Johnson & Johnson Consumer Inc. Modified release solid or semi-solid dosage forms
US20090004248A1 (en) * 2007-06-29 2009-01-01 Frank Bunick Dual portion dosage lozenge form
US20090060983A1 (en) * 2007-08-30 2009-03-05 Bunick Frank J Method And Composition For Making An Orally Disintegrating Dosage Form
CN101801354A (zh) * 2007-09-17 2010-08-11 麦克内尔-Ppc股份有限公司 含有由聚乙烯醇和聚乙二醇所成的共聚物和树胶的浸涂组合物
EP2217213B1 (en) * 2007-10-31 2017-05-24 Johnson & Johnson Consumer Inc. Orally disintegrative dosage form
US8357395B2 (en) * 2007-12-21 2013-01-22 Mcneil-Ppc, Inc. Manufacture of tablet
WO2009099831A2 (en) * 2008-01-31 2009-08-13 Mcneil-Ppc, Inc. Edible film-strips with modified release active ingredients
CA2711932A1 (en) * 2008-01-31 2009-08-13 Mcneil-Ppc, Inc. Edible film-strips for immediate release of active ingredients
CA2713548A1 (en) * 2008-02-19 2009-08-27 Mcneil-Ppc, Inc. Dip coated compositions containing a starch having a high amylose content
BRPI0915411A2 (pt) * 2008-06-26 2015-11-03 Mcneil Ppc Inc partículas revestidas contendo agentes farmaceuticamente ativos
US8323262B2 (en) 2008-07-08 2012-12-04 Hyperbranch Medical Technology, Inc. Self-contained medical applicators for multiple component formulations, and methods of use thereof
EP2364143A1 (en) * 2008-10-31 2011-09-14 McNeil-PPC, Inc. Osmotic tablet with a compressed outer coating
US20100247586A1 (en) * 2009-03-27 2010-09-30 Andreas Hugerth Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties
CN102470111A (zh) * 2009-06-29 2012-05-23 麦克内尔-Ppc股份有限公司 含充液胶囊的药物片剂
US20110070286A1 (en) * 2009-09-24 2011-03-24 Andreas Hugerth Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process
WO2012039788A1 (en) 2010-09-22 2012-03-29 Mcneil-Ppc, Inc. Multi-layered orally disintegrating tablet and the manufacture thereof
US20110318411A1 (en) 2010-06-24 2011-12-29 Luber Joseph R Multi-layered orally disintegrating tablet and the manufacture thereof
US9610224B2 (en) 2009-09-24 2017-04-04 Johnson & Johnson Consumer Inc. Manufacture of tablet in a die utilizing powder blend containing water-containing material
US8313768B2 (en) 2009-09-24 2012-11-20 Mcneil-Ppc, Inc. Manufacture of tablet having immediate release region and sustained release region
TWI461213B (zh) * 2009-11-05 2014-11-21 Fmc Corp 作為藥物賦形劑之微晶纖維素及磷酸鈣之組合物
RU2013118252A (ru) 2010-09-22 2014-10-27 МакНЕЙЛ-ППС, ИНК. Производство таблеток из порошковой смеси, обработанной излучением
MX2010012479A (es) * 2010-11-16 2012-05-16 Posi Visionary Solutions Llp Composicion farmaceutica de administracion oral para el tratamiento del sindrome de intestino irritable, a base de un modificador de la motilidad intestinal, un agente que previene la retencion de gases y enzimas digestivas y proceso para su preparacion.
RU2602745C2 (ru) * 2011-12-14 2016-11-20 Дисфар Интернэшнл Б.В. Состав с симетиконом
RU2609836C2 (ru) 2012-02-07 2017-02-06 МакНЕЙЛ-ППС, ИНК. Быстроразрушающиеся таблетки с покрытием
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US20130295174A1 (en) 2012-05-01 2013-11-07 Mcneil-Ppc, Inc. Tablet comprising a first and second region
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
GB201315558D0 (en) 2013-08-02 2013-10-16 Tate & Lyle Ingredients Sweetener compositions
GB201315559D0 (en) * 2013-08-02 2013-10-16 Tate & Lyle Ingredients Sweetener compositions
KR20160107254A (ko) 2014-01-10 2016-09-13 존슨 앤드 존슨 컨수머 인코포레이티드 고주파 및 손실 코팅된 입자를 사용하여 정제를 제조하는 방법
US12168004B2 (en) 2014-02-05 2024-12-17 Merck Sharp & Dohme Llc Treatment of migraine
WO2015119848A1 (en) * 2014-02-05 2015-08-13 Merck Sharp & Dohme Corp. Tablet formulation for cgrp-active compounds
WO2016114734A1 (en) 2015-01-16 2016-07-21 Biofarma Ilaç Sanayi Ve Ticaret A. Ş. Pharmaceutical formulation of trimebutine maleate and simethicone comprising acidifying agent
MA41620A (fr) 2015-05-14 2018-01-09 Abdi Ibrahim Ilac Sanayi Ve Ticaret A S Composition pharmaceutique comprenant de la siméthicone et de l'otilonium
EP3294269A1 (en) 2015-06-12 2018-03-21 Santa Farma Ilaç Sanayi A.S. Oral pharmaceutical composition comprising otilonium bromide and simethicone with certain bulk density and improved dissolution characteristics
EP3487485A2 (en) 2016-07-19 2019-05-29 Johnson & Johnson Consumer Inc. Tablets having discontinuous coated regions
US10583089B2 (en) 2016-07-19 2020-03-10 Johnson & Johnson Consumer Inc. Tablets having discontinuous coated regions
AU2017363357B2 (en) 2016-11-28 2023-10-05 Kenvue Brands Llc Process for making a coated dosage form
BR112019010671A8 (pt) 2016-11-28 2022-08-09 Currahee Holding Company Inc Composições líquidas que compreendem um agente mucoadesivo
MX385008B (es) * 2016-12-14 2025-03-14 Rhein Siegfried Sa De Cv Composicion mejorada de lansoprazol y simeticona y procesos para prepararla.
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
US10500155B2 (en) 2017-05-22 2019-12-10 Johnson & Johnson Consumer Inc. Lozenge dosage form having a disintegrative tablet portion and a candy glass shell portion
CN107573689A (zh) * 2017-08-03 2018-01-12 江苏汉斯通药业有限公司 西甲硅油的制备方法
CN111132667A (zh) * 2017-09-29 2020-05-08 强生消费者公司 固体西甲硅油颗粒及其剂型
US20190224129A1 (en) 2018-01-22 2019-07-25 Johnson & Johnson Consumer Inc. Perforated capsules
US12383545B1 (en) 2018-06-08 2025-08-12 Allergan Pharmaceuticals International Limited Treatment of migraine
EP4188375A4 (en) 2020-07-29 2024-07-24 Allergan Pharmaceuticals International Limited MIGRAINE TREATMENT
AU2021409718A1 (en) 2020-12-22 2023-07-13 Allergan Pharmaceuticals International Limited Treatment of migraine
EP4408418A1 (en) 2021-09-27 2024-08-07 Allergan Pharmaceuticals International Limited Combination comprising atogepant for treating migraine
CN118251215A (zh) 2021-11-16 2024-06-25 强生消费者公司 含有西甲硅油的可定制剂型
CN116159032A (zh) * 2023-03-31 2023-05-26 成都恒瑞制药有限公司 盐酸西替利嗪片及其制备方法
AU2024249349A1 (en) 2023-03-31 2025-09-11 Kenvue Brands Llc Therapeutic liquid compositions
WO2024206438A1 (en) 2023-03-31 2024-10-03 Johnson & Johnson Consumer Inc. Therapeutic suspension compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE25205E (en) * 1960-10-10 1962-07-24 Silicone composition for the relief of
US4127650A (en) * 1975-03-31 1978-11-28 William H. Rorer, Inc. Medicinal simethicone containing composition and its method of production
US4396604A (en) * 1982-05-17 1983-08-02 Norcliff Thayer, Inc. Simethicone antacid lozenge
US4557916A (en) * 1984-10-22 1985-12-10 J. M. Huber Corporation Synthetic calcium silicates and methods of preparation
US4867989A (en) * 1986-09-09 1989-09-19 Warner-Lambert Company Chewing gum mineral supplement
US4906478A (en) * 1988-12-12 1990-03-06 Valentine Enterprises, Inc. Simethicone/calcium silicate composition
US5073384A (en) * 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate
US5275822A (en) * 1989-10-19 1994-01-04 Valentine Enterprises, Inc. Defoaming composition
KR920002149A (ko) * 1990-07-03 1992-02-28 안드레아 엘. 콜비 비스테로이드계 소염제에 의해 유발된 위장 장애 증상을 완화시키기 위한 약제 조성물 및 이를 완화시키는 방법
GR1002332B (el) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
FR2705966B1 (fr) * 1993-06-04 1995-08-25 Dow Corning Sa Compositions antimousse utiles notamment pour le traitement de troubles gastriques.
US5498426A (en) * 1994-10-03 1996-03-12 The Procter & Gamble Company Liquid antacid compositions

Also Published As

Publication number Publication date
CZ294084B6 (cs) 2004-10-13
ATE259236T1 (de) 2004-02-15
ZA986338B (en) 2000-01-17
CN1207898A (zh) 1999-02-17
AU7508898A (en) 1999-01-28
AU727271B2 (en) 2000-12-07
EP0891776A1 (en) 1999-01-20
PL189988B1 (pl) 2005-10-31
US6103260A (en) 2000-08-15
PT891776E (pt) 2004-05-31
JPH1192387A (ja) 1999-04-06
KR19990013918A (ko) 1999-02-25
DE69821553D1 (de) 2004-03-18
EP0891776B1 (en) 2004-02-11
HUP9801615A2 (hu) 1999-07-28
PL327491A1 (en) 1999-01-18
DE69821553T2 (de) 2004-12-23
NZ330915A (en) 1999-06-29
HUP9801615A3 (en) 2000-06-28
CN1267106C (zh) 2006-08-02
KR100549355B1 (ko) 2006-04-06
BR9802487B1 (pt) 2010-05-18
RU2216317C2 (ru) 2003-11-20
CZ222198A3 (cs) 1999-02-17
BR9802487A (pt) 1999-09-08
ES2216244T3 (es) 2004-10-16
HU9801615D0 (en) 1998-09-28
AR013227A1 (es) 2000-12-13

Similar Documents

Publication Publication Date Title
DK0891776T3 (da) Granulær sammensætning omfattende simethicon og granulær vandfri calciumphosphat
DE69809158D1 (de) Calciumphosphatzement und Calciumphosphatzementzusammensetzung
IS5341A (is) Samsett meðferð sem inniheldur atórvastatin og þrýstingslækkandi miðil
DE69840069D1 (de) Kalziumphosphat-mikroträger und -mikrokugeln
FI962343A7 (fi) Luunkiinnitin
DE69824961D1 (de) Härtbare zusammensetzung
ATE232556T1 (de) Brausezusammensetzungen sowie trockene brausegranulate
ID22878A (id) Komposisi aktif secara terapi
NO20006488D0 (no) Sammensetning og anvendelse
DK0804078T3 (da) Sammensætning og anvendelse deraf
DE69715801D1 (de) Granuläre Zusammensetzungen von E-pthalimido-Peroxyhexansäure
DK1300129T3 (da) Implantathætteglas
BR9407743A (pt) Composiçao oral de peróxido de cálcio-bicarbonato
IS5784A (is) Lífræn fosfórsambönd og notkun theirra
DE59404089D1 (de) Streckrollenaggregat
DE69821948D1 (de) Härtbare zusammensetzung
DK0847691T3 (da) Granulær pesticidsammensætning
DE69931541D1 (de) Calciumphosphatzement
DE59605208D1 (de) Düngemittel
DE69820919D1 (de) Mit Wasser quellbare Zusammensetzungen und Dichtungsmassen
DE69716384D1 (de) Granularer hydratisierungswirkstoff
NO20012542D0 (no) Organofosforforbindelser og anvendelse derav
DE69615714D1 (de) Phosphat-zusammensetzung und ihre verwendung
FR2754739B1 (fr) Compositions anti-mousse et compositions anhydres intermediaires
NO20003766D0 (no) PAI-2 og t-PA som diagnostiske markører for periodontale sykdommer